Pharma Ties Common in Medical Schools

Study Economically Links Medical Leaders to Industry

By Staff Reporters

56372274A new study suggests that nearly two of three academic leaders surveyed at US medical schools and teaching hospitals have financial ties to the pharmaceutical industry, illustrating how pervasive these relationships have become; researchers say.

Assessment

This link to a related report was sent in by a reader-advocate, with our thanks: http://www.msnbc.msn.com/id/21333262 

Conclusion: Now, is anyone really surprised? Your comments are appreciated.

Get our Widget: Get this widget!

Our Other Print Books and Related Information Sources:

Practice Management: http://www.springerpub.com/prod.aspx?prod_id=23759

Physician Financial Planning: http://www.jbpub.com/catalog/0763745790

Medical Risk Management: http://www.jbpub.com/catalog/9780763733421

Healthcare Organizations: www.HealthcareFinancials.com

Health Administration Terms: www.HealthDictionarySeries.com

Physician Advisors: www.CertifiedMedicalPlanner.com

Subscribe Now: Did you like this Medical Executive-Post, or find it helpful, interesting and informative? Want to get the latest ME-Ps delivered to your email box each morning? Just subscribe using the link below. You can unsubscribe at any time. Security is assured.

Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos

Sponsors Welcomed: And, credible sponsors and like-minded advertisers are always welcomed.

Link: https://healthcarefinancials.wordpress.com/2007/11/11/advertise

2 Responses

  1. Health System Bans Drug Company Logos

    According to the Minneapolis Star-Tribune, the SMDC Health System of Duluth, MN just launched a new policy that bans all drug company “freebies” with company names or logos on them.

    Thanks to the new policy, SMDC employees have turned in thousands of items, including clocks, mugs, calculators, tape dispensers and stress balls. Of course, the Pharmaceutical Research and Manufacturers of America [PRMA] called the measure “draconian.”

    The health system is also refusing to let drug companies sponsor educational conferences or display materials at them; a move which will cost the organization at least $100,000 a year.

    Yet, SMDC hasn’t banned all drug companies from its presence. It’s still going to allow them to provide educational sessions for doctors and patients. However, the materials they use must pass through the system’s educational specialists, who will attempt to fact-check the content and provide scientific balance.

    From one nurse’s POV – forget the golf balls and other tschochkes – and try something of real value.

    Theresa; RN

    Like

  2. Fewer Drug Reps Seeing Doctors

    Doctors haven’t gotten any more open to visits from pharma reps over the last year. The number of physicians who were “rep-accessible,” defined as meeting with at least 70% of salespeople who came calling, dropped by 18% from last year, according to sales and marketing consultants ZS Associates.

    http://blogs.wsj.com/health/2010/05/06/more-doctors-giving-pharma-sales-reps-the-cold-shoulder/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+wsj%2Fhealth%2Ffeed+%28WSJ.com%3A+Health+Blog%29&mod=smallbusiness

    Jeff

    Like

Leave a comment